Navigation Links
Romark Announces Data Presented at AASLD Meeting 2010
Date:11/1/2010

uesday, November 2, 7:00 am – 12:00 pm.

Dr. Korba reports an extensive series of studies designed to evaluate mechanisms of potential resistance of hepatitis C virus (HCV) to nitazoxanide.  These studies show that nitazoxanide does not induce mutations in HCV that confer resistance.  Importantly, these findings distinguish nitazoxanide from direct-acting antiviral drugs (e.g., protease and polymerase inhibitors) and other host-targeting anti-HCV agents, such as the cyclophilin inhibitors, where resistance appears to be primarily due to mutations in viral sequences.

2. Augmentation of Interferon Signaling Pathway by Nitazoxanide: A Novel Therapeutic Strategy for Relapsers to Peginterferon and Ribavirin Therapy. Crystal Wang(1), Ziaozhen Zhang(1), Anu Osinusi(1), Henry Masur(2), Dawn Fishbein(3), Shyam Kottilil(1); (1)LIR, NIAID, NIH, Bethesda, MD; (2)CCMD, CC, NIH, Bethesda, MD; (3)SAIC-Frederick, Inc., CMRP in support of CCMD, NIH, Frederick, MD. Poster session: Tuesday, November 2, 7:00 am – 12:00 pm.

This team of researchers from NIH reports that nitazoxanide has potent in vitro anti-HCV activity in the Huh7.5/JFH-1 HCV genotype 2a continuous cell culture system and that the activity is synergistic with interferon. In PBMCs collected from SVR and relapser patients co-infected with HCV and HIV, nitazoxanide significantly enhanced interferon-inducible gene expression.  The addition of nitazoxanide to interferon also significantly enhanced interferon-inducible gene expression compared to interferon alone. Importantly, these investigators also report, for the first time, the activity of new nitazoxanide-related compounds (thiazolides) against HCV.

3. Nitazoxanide for the Prevention of Recurrent Hepatitis C Virus Infection after Liver Transplantation: A Pilot Study.  Sumeet K. Asrani, Stacy Anderson, Jennie Wilnso, Laura J. Myhre, Julie Heimbach, Walter K. Kremers, Charles B. Rosen, Terry M. Ther
'/>"/>

SOURCE Romark Laboratories, L.C.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Romark and Intercell Join Forces in Combining Therapies Against Hepatitis C
2. Intercell and Romark Join Forces in Combining Therapies Against Hepatitis C
3. NeuroFocus and New Scientist Magazine Apply Neuromarketing to Select Cover Design
4. Romark Initiates Clinical Trial of Alinia for Treatment of Influenza
5. Romark Laboratories Completes Enrollment in U.S. Phase II Study of Nitazoxanide for Chronic Hepatitis C Genotype 1 Non-Responders
6. Romark Announces Presentation of New Data for Nitazoxanide in Chronic Hepatitis C at EASL 2008
7. Romark Laboratories Initiates Phase II Study of Nitazoxanide in Treatment-Naive Patients With Chronic Hepatitis C Genotype 1
8. Romark Laboratories Raises $18 Million in Institutional Financing
9. Romark Initiates Clinical Trial of Alinia(R) for Chronic Hepatitis C in the United States
10. AVANIR Pharmaceuticals Announces FDA Approval of NUEDEXTA™
11. Stryker Announces Acquisition of Privately-Held Porex Surgical
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/1/2015)...  BioPharmX Corporation (NYSE MKT: BPMX) today announced the ... 3,636,364 shares of its common stock at a price ... granted the underwriters a 30-day option to purchase up ... public offering price. In addition, Korea Investment ... agreed to purchase 1,081,081 shares of common stock from ...
(Date:7/1/2015)... SAN FRANCISCO , July 1, 2015 ... health market) is expected to reach USD 49,119.2 million ... View Research, Inc. Monitoring services is expected to remain ... revenue of USD 1,227.5 million in 2012, and an ...      (Logo: http://photos.prnewswire.com/prnh/20150105/723757 ) , ...
(Date:7/1/2015)... , July 1, 2015 ... its Executive Board. Mr. Gert Weber has ... Invest AG as Chief Executive Officer (CEO) ... July 1 st , 2015. Mr. Weber brings more ... technological industries and has filled various executive management positions, ...
Breaking Medicine Technology:BioPharmX Corporation Closes Underwritten Public Offering of Common Stock 2BioPharmX Corporation Closes Underwritten Public Offering of Common Stock 3mHealth Market Worth $ 49,119.2 Million By 2020: Grand View Research, Inc. 2mHealth Market Worth $ 49,119.2 Million By 2020: Grand View Research, Inc. 3mHealth Market Worth $ 49,119.2 Million By 2020: Grand View Research, Inc. 4mHealth Market Worth $ 49,119.2 Million By 2020: Grand View Research, Inc. 5Haselmeier Group Announces the Extension and Reorganization of its Executive Board 2
... 2011 /PRNewswire/ -- PRA, a leading Clinical ... Romania to further strengthen our coverage of the Balkan ... projects in the neighboring Republic of Moldova. ... in Romania, the PRA staff has steadily increased and ...
... Aug. 22, 2011 Reportlinker.com announces ... is available in its catalogue: ... Assessments of Leading Suppliers ... This report provides diagnostic imaging industry ...
Cached Medicine Technology:PRA Opens Office in Romania 2Global MRI Market: Strategic Assessments of Leading Suppliers 2Global MRI Market: Strategic Assessments of Leading Suppliers 3Global MRI Market: Strategic Assessments of Leading Suppliers 4Global MRI Market: Strategic Assessments of Leading Suppliers 5
(Date:7/1/2015)... ... July 01, 2015 , ... There ... liberty. Americans have been arguing over laws governing sexuality since the first Pilgrims ... a forthcoming historical comparative biography by Cindy Safronoff reveals. Crossing Swords: Mary Baker ...
(Date:7/1/2015)... ... 2015 , ... SuiteRx, innovative leaders in pharmacy performance management ... announces the most recent positioning of SuiteRx CEO, Nicholas Zener Pharm. D., and ... Venetian Las Vegas, Nevada. During this event, SuiteRx will be highlighting the ...
(Date:7/1/2015)... ... July 01, 2015 , ... A healthy eating ... chickens and eggs. Eating organic foods and products can help limit the exposure ... friendly than production chicken farming. Choosing home raised chickens and eggs that do ...
(Date:7/1/2015)... ... ... Dr. Surya Challa of Chesapeake Vein Center and MedSpa in Chesapeake, VA will ... non-invasive CoolSculpting . On the show, Dr. Challa will explain how CoolSculpting can ... Cryolipolysis to literally freeze stubborn, unwanted fat away and give patients the slim, trim ...
(Date:7/1/2015)... (PRWEB) , ... July 01, 2015 , ... Renowned ... the dates for the 2016 Dallas Rhinoplasty Symposium . Set for March 6th ... , Designed to take participants from the basic training and fundamentals of nasal surgery ...
Breaking Medicine News(10 mins):Health News:Biography by Cindy Safronoff to be Released July 4 Explores an 1870s Marriage Debate Over Women’s Rights and the Implications of the American Revolution for Sexuality 2Health News:Biography by Cindy Safronoff to be Released July 4 Explores an 1870s Marriage Debate Over Women’s Rights and the Implications of the American Revolution for Sexuality 3Health News:Biography by Cindy Safronoff to be Released July 4 Explores an 1870s Marriage Debate Over Women’s Rights and the Implications of the American Revolution for Sexuality 4Health News:Pharmacy Software Vendor, SuiteRx IPS, Officially Introducing Newly Appointed CEO at Cardinal Health Event in Las Vegas, Nevada 2Health News:Pharmacy Software Vendor, SuiteRx IPS, Officially Introducing Newly Appointed CEO at Cardinal Health Event in Las Vegas, Nevada 3Health News:Pharmacy Software Vendor, SuiteRx IPS, Officially Introducing Newly Appointed CEO at Cardinal Health Event in Las Vegas, Nevada 4Health News:Chicken Coop Condo Offer New Chicken Coop Designs 2Health News:Dr. Surya Challa of Chesapeake Vein Center and MedSpa Will be Featured on The Hampton Roads Show on WAVY-TV 2Health News:Dr. Surya Challa of Chesapeake Vein Center and MedSpa Will be Featured on The Hampton Roads Show on WAVY-TV 3Health News:Dr. Rod J. Rohrich Announces Dates for 2016 Dallas Rhinoplasty Symposium 2Health News:Dr. Rod J. Rohrich Announces Dates for 2016 Dallas Rhinoplasty Symposium 3
... University of California, San Diego (UCSD) School of Medicine ... that play key roles// in inflammation and in the ... of infection and inflammation. These findings could potentially lead ... in patients. ,The research, reported in the December ...
... becoming infected with lymphocytic choriomeningitis virus (LCMV), an infectious ... can cause severe brain damage in a fetus. ... the winter months, when rodents seek shelter in homes, ... at the University of Iowa Roy J. and Lucille ...
... gets underway, doctors in this week’s BMJ say that more ... sudden cardiac deaths//. ,Automated external defibrillators (AEDs) are electrical ... placed in busy public places like airports and stadiums. ... the world and is a serious trigger for sudden cardiac ...
... made in the past two decades are leading to ... and better outcomes for patients suffering from a condition ... senior vice president for Academic Affairs and director of ... an update on medical progress related to the condition ...
... Herbal Formulations Sleep Ease Dietary Supplement, a product containing the ... when used just for few months. // ,Estazolam ... only under a practitioner’s prescription as it may have a ... hallucinations and depression. Hence it is not legal to sell ...
... AMA Vice-President, Dr Choong-Siew Yong, today cautioned people with ... extra care during periods of smoke haze. ... health, but that's particularly true for people with pre-existing ... ,'Large airborne particles such as embers can irritate the ...
Cached Medicine News:Health News:Researchers Discover Internal Compass of Immune Cells 2Health News:Pregnant Women Can Minimize Risk Of Rodent-Based Virus 2Health News:Defibrillators Should Be Available in Ski Resorts 2Health News:Options Improving for Patients With Acromegaly and Gigantism 2Health News:Options Improving for Patients With Acromegaly and Gigantism 3Health News:Asthma Warning As Bushfires Burn 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: